Lidak preclinical data

LDAKA (La Jolla, Calif.) reported that Lidakol, which inhibits viral replication, blocked infection by the simian immunodeficiency virus in female rhesus monkeys treated intravaginally with Lidakol and then exposed to SIV.

Five of the six animals remained seronegative for more than four months after inoculation. Two control animals exposed to the virus were infected. ...